SHAWN BROWN: Open Payments
NPI 1609910108 · WADDY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,228 in 108 payments from 15 companies in 2025. Trend: 2023 $1,751 · 2024 $2,455 · 2025 $2,228
Food & beverage: $2,228
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $435 |
| Axsome Therapeutics, Inc. | 7 | $408 |
| Otsuka America Pharmaceutical, Inc. | 13 | $235 |
| Janssen Pharmaceuticals, Inc | 16 | $224 |
| Vanda Pharmaceuticals Inc. | 7 | $172 |
| Teva Pharmaceuticals USA, Inc. | 9 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $140 |
| Biogen, Inc. | 6 | $123 |
| Alkermes, Inc. | 4 | $101 |
| HARMONY BIOSCIENCES LLC | 3 | $71 |
Products named: VRAYLAR, Auvelity, REXULTI, INVEGA SUSTENNA, CAPLYTA, FANAPT, ZURZUVAE, LYBALVI.
Industry payments across KY — which companies pay providers there.
